Pomanda estimates the enterprise value of ABBOTT DIABETES CARE LIMITED at £286.8m based on a Turnover of £181.3m and 1.58x industry multiple (adjusted for size and gross margin).
abbott diabetes care limitedEstimated Valuation
£5b
Pomanda estimates the enterprise value of ABBOTT DIABETES CARE LIMITED at £5b based on an EBITDA of £551.1m and a 9.05x industry multiple (adjusted for size and gross margin).
abbott diabetes care limitedEstimated Valuation
£1.1b
Pomanda estimates the enterprise value of ABBOTT DIABETES CARE LIMITED at £1.1b based on Net Assets of £508.4m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Abbott Diabetes Care LimitedOverview
Abbott Diabetes Care Limited is a live company located in witney, OX29 0YL with a Companies House number of 02548046. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in October 1990, it's largest shareholder is
abbott laboratories ltd
with a 100% stake. Abbott Diabetes Care Limited is a mature,
mega sized company, Pomanda has estimated its turnover at
£181.3m with
high
growth in recent years.
Pomanda's financial health check has awarded Abbott Diabetes Care Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
8 Strong
0 Regular
3 Weak
Size
annual sales of £181.3m, make it larger than the average company (£17.8m)
£181.3m - Abbott Diabetes Care Limited
£17.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 21%, show it is growing at a faster rate (6.2%)
21% - Abbott Diabetes Care Limited
6.2% - Industry AVG
Production
with a gross margin of 19.8%, this company has a higher cost of product (37.4%)
19.8% - Abbott Diabetes Care Limited
37.4% - Industry AVG
Profitability
an operating margin of 298.9% make it more profitable than the average company (6%)
298.9% - Abbott Diabetes Care Limited
6% - Industry AVG
Employees
with 822 employees, this is above the industry average (90)
822 - Abbott Diabetes Care Limited
90 - Industry AVG
Pay Structure
on an average salary of £71.2k, the company has a higher pay structure (£49.5k)
£71.2k - Abbott Diabetes Care Limited
£49.5k - Industry AVG
Efficiency
resulting in sales per employee of £220.5k, this is more efficient (£179.4k)
£220.5k - Abbott Diabetes Care Limited
£179.4k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Abbott Diabetes Care Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 62 days, this is slower than average (35 days)
62 days - Abbott Diabetes Care Limited
35 days - Industry AVG
Stock Days
it holds stock equivalent to 23 days, this is less than average (95 days)
23 days - Abbott Diabetes Care Limited
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (11 weeks)
0 weeks - Abbott Diabetes Care Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 35.2%, this is a lower level of debt than the average (41.9%)
35.2% - Abbott Diabetes Care Limited
41.9% - Industry AVG
ABBOTT DIABETES CARE LIMITED financials
EXPORT
Abbott Diabetes Care Limited's latest turnover from December 2023 is £181.3 million and the company has net assets of £508.4 million. According to their latest financial statements, Abbott Diabetes Care Limited has 822 employees and maintains cash reserves of £3.8 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Nov 2009
Turnover
181,273,000
150,400,000
100,642,000
102,357,000
120,350,000
99,999,000
72,785,000
55,468,000
51,923,000
48,296,000
45,433,000
44,076,000
42,657,000
44,400,000
52,319,000
Other Income Or Grants
Cost Of Sales
145,419,000
127,871,000
120,638,000
106,977,000
98,137,000
82,393,000
72,990,000
50,268,000
46,835,000
43,761,000
41,076,000
39,821,000
38,919,000
40,833,000
48,236,000
Gross Profit
35,854,000
22,529,000
-19,996,000
-4,620,000
22,213,000
17,606,000
-205,000
5,200,000
5,088,000
4,535,000
4,357,000
4,255,000
3,738,000
3,567,000
4,083,000
Admin Expenses
-505,946,000
-314,999,000
-79,041,000
-7,569,000
34,720,000
120,179,000
52,880,000
31,000
2,000
23,000
40,000
41,000
42,000
42,000
Operating Profit
541,800,000
337,528,000
59,045,000
2,949,000
-12,507,000
-102,573,000
-53,085,000
5,169,000
5,086,000
4,512,000
4,317,000
4,214,000
3,696,000
3,525,000
4,083,000
Interest Payable
10,106,000
6,813,000
443,000
564,000
1,869,000
630,000
161,000
304,000
310,000
187,000
246,000
387,000
341,000
358,000
708,000
Interest Receivable
5,029,000
2,879,000
56,000
364,000
35,000
30,000
54,000
66,000
59,000
64,000
31,000
90,000
412,000
Pre-Tax Profit
536,723,000
333,594,000
58,658,000
2,749,000
-14,376,000
-103,203,000
-53,211,000
4,895,000
4,830,000
4,391,000
4,130,000
3,891,000
3,386,000
3,257,000
3,787,000
Tax
-135,022,000
-64,705,000
-2,432,000
-948,000
272,000
-132,000
-814,000
-102,000
-1,501,000
-3,413,000
592,000
427,000
-1,145,000
797,000
-688,000
Profit After Tax
401,701,000
268,889,000
56,226,000
1,801,000
-14,104,000
-103,335,000
-54,025,000
4,793,000
3,329,000
978,000
4,722,000
4,318,000
2,241,000
4,054,000
3,099,000
Dividends Paid
20,000,000
Retained Profit
401,701,000
268,889,000
56,226,000
1,801,000
-14,104,000
-103,335,000
-54,025,000
4,793,000
3,329,000
978,000
4,722,000
4,318,000
2,241,000
-15,946,000
3,099,000
Employee Costs
58,486,000
52,632,000
50,892,000
44,953,000
39,568,000
35,985,000
31,129,000
30,135,000
27,186,000
26,065,000
25,700,000
25,795,000
26,580,000
27,425,000
30,033,000
Number Of Employees
822
854
813
922
825
692
627
553
573
554
516
515
562
544
640
EBITDA*
551,088,000
347,124,000
67,695,000
9,481,000
-6,119,000
-96,361,000
-47,264,000
9,602,000
9,097,000
8,401,000
8,165,000
8,559,000
7,964,000
8,953,000
9,274,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Nov 2009
Tangible Assets
99,153,000
83,478,000
86,667,000
88,074,000
79,045,000
71,226,000
59,151,000
56,600,000
42,165,000
38,050,000
40,161,000
38,091,000
40,455,000
43,719,000
47,009,000
Intangible Assets
78,000
88,000
Investments & Other
8,162,000
514,000
1,469,000
Debtors (Due After 1 year)
4,031,000
7,378,000
Total Fixed Assets
103,262,000
90,944,000
94,829,000
88,074,000
79,045,000
71,226,000
59,665,000
58,069,000
42,165,000
38,050,000
40,161,000
38,091,000
40,455,000
43,719,000
47,009,000
Stock & work in progress
9,514,000
9,577,000
9,157,000
6,063,000
7,191,000
10,713,000
4,225,000
5,339,000
1,455,000
870,000
556,000
Trade Debtors
1,725,000
804,000
882,000
Group Debtors
664,115,000
673,534,000
298,974,000
122,537,000
68,686,000
32,883,000
23,598,000
51,221,000
47,355,000
41,167,000
33,958,000
39,498,000
34,504,000
30,764,000
36,125,000
Misc Debtors
3,590,000
1,257,000
17,584,000
2,684,000
6,154,000
1,487,000
4,784,000
3,711,000
2,200,000
2,148,000
4,532,000
3,065,000
2,315,000
2,388,000
3,577,000
Cash
3,819,000
2,296,000
3,198,000
1,603,000
1,249,000
3,149,000
1,757,000
2,378,000
1,756,000
1,810,000
1,415,000
2,783,000
815,000
1,228,000
misc current assets
total current assets
681,038,000
686,664,000
328,913,000
134,612,000
83,280,000
49,036,000
35,246,000
62,649,000
52,766,000
45,995,000
40,461,000
45,346,000
37,634,000
34,380,000
39,702,000
total assets
784,300,000
777,608,000
423,742,000
222,686,000
162,325,000
120,262,000
94,911,000
120,718,000
94,931,000
84,045,000
80,622,000
83,437,000
78,089,000
78,099,000
86,711,000
Bank overdraft
53,000
Bank loan
Trade Creditors
25,023,000
11,190,000
13,948,000
13,951,000
15,640,000
15,323,000
8,137,000
8,615,000
4,099,000
3,755,000
2,438,000
2,017,000
3,611,000
2,792,000
4,399,000
Group/Directors Accounts
109,886,000
457,119,000
406,318,000
323,517,000
262,132,000
210,262,000
89,216,000
60,368,000
43,646,000
36,052,000
37,893,000
20,278,000
18,254,000
22,229,000
10,267,000
other short term finances
hp & lease commitments
37,000
35,000
45,000
other current liabilities
140,922,000
48,809,000
11,854,000
9,931,000
11,498,000
8,648,000
8,234,000
8,386,000
8,641,000
8,939,000
5,970,000
6,228,000
5,033,000
4,310,000
6,482,000
total current liabilities
275,868,000
517,153,000
432,165,000
347,399,000
289,270,000
234,233,000
105,587,000
77,369,000
56,386,000
48,746,000
46,301,000
28,523,000
26,898,000
29,331,000
21,201,000
loans
25,315,000
25,315,000
25,315,000
25,315,000
hp & lease commitments
41,000
53,000
64,000
Accruals and Deferred Income
other liabilities
provisions
36,000
710,000
1,020,000
2,595,000
total long term liabilities
41,000
53,000
64,000
36,000
25,315,000
26,025,000
26,335,000
27,910,000
total liabilities
275,909,000
517,206,000
432,229,000
347,399,000
289,270,000
234,233,000
105,587,000
77,369,000
56,422,000
48,746,000
46,301,000
53,838,000
52,923,000
55,666,000
49,111,000
net assets
508,391,000
260,402,000
-8,487,000
-124,713,000
-126,945,000
-113,971,000
-10,676,000
43,349,000
38,509,000
35,299,000
34,321,000
29,599,000
25,166,000
22,433,000
37,600,000
total shareholders funds
508,391,000
260,402,000
-8,487,000
-124,713,000
-126,945,000
-113,971,000
-10,676,000
43,349,000
38,509,000
35,299,000
34,321,000
29,599,000
25,166,000
22,433,000
37,600,000
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Nov 2009
Operating Activities
Operating Profit
541,800,000
337,528,000
59,045,000
2,949,000
-12,507,000
-102,573,000
-53,085,000
5,169,000
5,086,000
4,512,000
4,317,000
4,214,000
3,696,000
3,525,000
4,083,000
Depreciation
9,288,000
9,596,000
8,650,000
6,532,000
6,388,000
6,212,000
5,821,000
4,433,000
4,011,000
3,889,000
3,848,000
4,345,000
4,268,000
5,428,000
5,191,000
Amortisation
Tax
-135,022,000
-64,705,000
-2,432,000
-948,000
272,000
-132,000
-814,000
-102,000
-1,501,000
-3,413,000
592,000
427,000
-1,145,000
797,000
-688,000
Stock
-63,000
420,000
3,094,000
-1,128,000
-3,522,000
6,488,000
-1,114,000
3,884,000
585,000
314,000
556,000
Debtors
-10,433,000
365,611,000
189,612,000
52,106,000
39,666,000
5,910,000
-25,668,000
5,377,000
6,240,000
4,825,000
-4,073,000
5,744,000
3,667,000
-6,550,000
39,702,000
Creditors
13,833,000
-2,758,000
-3,000
-1,689,000
317,000
7,186,000
-478,000
4,516,000
344,000
1,317,000
421,000
-1,594,000
819,000
-1,607,000
4,399,000
Accruals and Deferred Income
92,113,000
36,955,000
1,923,000
-1,567,000
2,850,000
414,000
-152,000
-255,000
-298,000
2,969,000
-258,000
1,195,000
723,000
-2,172,000
6,482,000
Deferred Taxes & Provisions
-36,000
36,000
-710,000
-310,000
-1,575,000
2,595,000
Cash flow from operations
532,508,000
-49,415,000
-125,523,000
-45,701,000
-38,824,000
-101,291,000
-21,926,000
4,464,000
853,000
4,135,000
12,437,000
2,133,000
4,384,000
10,946,000
-17,640,000
Investing Activities
capital expenditure
-24,953,000
-6,495,000
-7,243,000
-15,561,000
-14,207,000
-18,287,000
-8,372,000
-18,868,000
-8,126,000
-1,778,000
-5,918,000
-1,981,000
-1,004,000
-2,138,000
-52,200,000
Change in Investments
-8,162,000
8,162,000
-514,000
-955,000
1,469,000
cash flow from investments
-24,953,000
1,667,000
-15,405,000
-15,561,000
-14,207,000
-17,773,000
-7,417,000
-20,337,000
-8,126,000
-1,778,000
-5,918,000
-1,981,000
-1,004,000
-2,138,000
-52,200,000
Financing Activities
Bank loans
Group/Directors Accounts
-347,233,000
50,801,000
82,801,000
61,385,000
51,870,000
121,046,000
28,848,000
16,722,000
7,594,000
-1,841,000
17,615,000
2,024,000
-3,975,000
11,962,000
10,267,000
Other Short Term Loans
Long term loans
-25,315,000
25,315,000
Hire Purchase and Lease Commitments
-10,000
-21,000
109,000
other long term liabilities
share issue
-153,712,000
60,000,000
431,000
1,130,000
40,000
47,000
-119,000
115,000
492,000
779,000
34,501,000
interest
-5,077,000
-3,934,000
-387,000
-200,000
-1,869,000
-630,000
-126,000
-274,000
-256,000
-121,000
-187,000
-323,000
-310,000
-268,000
-296,000
cash flow from financing
-506,032,000
46,846,000
142,523,000
61,616,000
51,131,000
120,456,000
28,722,000
16,495,000
7,219,000
-1,962,000
-7,887,000
1,816,000
-3,793,000
12,473,000
69,787,000
cash and cash equivalents
cash
1,523,000
-902,000
1,595,000
354,000
-1,900,000
1,392,000
-621,000
622,000
-54,000
395,000
-1,368,000
1,968,000
-413,000
1,228,000
overdraft
-53,000
53,000
change in cash
1,523,000
-902,000
1,595,000
354,000
-1,900,000
1,392,000
-621,000
622,000
-54,000
395,000
-1,368,000
1,968,000
-413,000
1,281,000
-53,000
abbott diabetes care limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for abbott diabetes care limited. Get real-time insights into abbott diabetes care limited's credit score, group structure and payment trends.
Perform a competitor analysis for abbott diabetes care limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mega companies, companies in OX29 area or any other competitors across 12 key performance metrics.
abbott diabetes care limited Ownership
ABBOTT DIABETES CARE LIMITED group structure
Abbott Diabetes Care Limited has no subsidiary companies.
The sole shareholder of Abbott Diabetes Care Limited is Abbott Laboratories Ltd.
abbott laboratories ltd
100%
abbott diabetes care limited directors
Abbott Diabetes Care Limited currently has 4 directors.
The longest serving directors include
Mr Christopher Bass (Nov 2016) and
Mr Shaun Smith (Oct 2018).
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
October 1990
age
35
incorporated
UK
ultimate parent company
ABBOTT LABORATORIES
accounts
Full Accounts
last accounts submitted
December 2023
previous names
medisense uk limited (August 2005)
medisense (u.k.) holding ltd. (April 1997)
accountant
-
auditor
ERNST & YOUNG
address
windrush park, range road, witney, oxon, OX29 0YL
Bank
BNP PARIBAS
Legal Advisor
-
abbott diabetes care limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to abbott diabetes care limited. Currently there are 2 open charges and 1 have been satisfied in the past.
abbott diabetes care limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ABBOTT DIABETES CARE LIMITED. This can take several minutes, an email will notify you when this has completed.
abbott diabetes care limitedCompanies House Filings - See Documents
